Authors:
Lu, Y
Sakamaki, S
Kuroda, H
Kusakabe, T
Konuma, Y
Akiyama, T
Fujimi, A
Takemoto, N
Nishiie, K
Matsunaga, T
Hirayama, Y
Kato, J
Kon, S
Kogawa, K
Niitsu, Y
Citation: Y. Lu et al., Prevention of lethal acute graft-versus-host disease in mice by oral administration of T helper 1 inhibitor, TAK-603, BLOOD, 97(4), 2001, pp. 1123-1130
Authors:
Ohkouchi, N
Kawamura, K
Takemoto, N
Ikehara, M
Nakatsuka, T
Citation: N. Ohkouchi et al., Implications of carbon isotope ratios of C-27-C-33 alkanes and C-37 alkenes for the sources of organic matter in the Southern Ocean surface sediments, GEOPHYS R L, 27(2), 2000, pp. 233-236
Authors:
Annoura, H
Nakanishi, K
Toba, T
Takemoto, N
Imajo, S
Miyajima, A
Tamura-Horikawa, Y
Tamura, S
Citation: H. Annoura et al., Discovery of (2S)-1-(4-amino-2,3,5-trimethylphenoxy)-3-{4-[4-(4-fluorobenzyl)phenyl]-1-piperazinyl}-2-propanol dimethanesulfonate (SUN N8075): A dualNa+ and Ca2+ channel blocker with antioxidant activity, J MED CHEM, 43(18), 2000, pp. 3372-3376
Authors:
Takemoto, N
Kamogawa, Y
Lee, HJ
Kurata, H
Arai, K
O'Garra, A
Arai, N
Miyatake, S
Citation: N. Takemoto et al., Cutting edge: Chromatin remodeling at the IL-4/IL-13 intergenic regulatoryregion for Th2-specific cytokine gene cluster, J IMMUNOL, 165(12), 2000, pp. 6687-6691
Authors:
Lee, HJ
Takemoto, N
Kurata, H
Kamogawa, Y
Miyatake, S
O'Garra, A
Arai, N
Citation: Hj. Lee et al., GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cells, J EXP MED, 192(1), 2000, pp. 105-115
Authors:
Sakamaki, S
Takayanagi, N
Yoshizaki, N
Hayashi, S
Takayama, T
Kato, J
Kogawa, K
Yamauchi, N
Takemoto, N
Nobuoka, A
Ayabe, T
Kohgo, Y
Niitsu, Y
Citation: S. Sakamaki et al., Autoantibodies against the specific epitope of human tropomyosin(s) detected by a peptide based enzyme immunoassay in sera of patients with ulcerative colitis show antibody dependent cell mediated cytotoxicity against HLA-DPw9 transfected L cells, GUT, 47(2), 2000, pp. 236-241
Authors:
Nakamura, Y
Takemoto, N
Kuroda, H
Ohgi, S
Citation: Y. Nakamura et al., The advantages of normocalcemic continuous warm cardioplegia over low calcemic cardioplegia in myocardial protection, SURG TODAY, 29(9), 1999, pp. 884-889
Authors:
Yamao, T
Kai, S
Kazami, A
Koizumi, M
Handa, T
Takemoto, N
Maruyama, M
Citation: T. Yamao et al., Tumor markers CEA, CA19-9 and CA125 in monitoring of response to systemic chemotherapy in patients with advanced gastric cancer, JPN J CLIN, 29(11), 1999, pp. 550-555
Authors:
Nakamura, Y
Kuroda, H
Takemoto, N
Ohgi, S
Mori, T
Citation: Y. Nakamura et al., Risk of low calcium and high magnesium in continuous warm hyperkalemic cardioplegia, ANN THORAC, 68(4), 1999, pp. 1295-1301
Authors:
Takemoto, N
Koyano-Nakagawa, N
Yokota, T
Arai, N
Miyatake, S
Arai, K
Citation: N. Takemoto et al., T(h)2-specific DNase I-hypersensitive sites in the murine IL-13 and IL-4 intergenic region, INT IMMUNOL, 10(12), 1998, pp. 1981-1985